Beam Therapeutics Inc. (BEAM) on GreekSoup https://greeksoup.ai/stocks/us/beam/ Every dated entry in the public record on Beam Therapeutics Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Beam Therapeutics Inc.: Form 144, JOHN M EVANS plans to sell 25,000 shares worth $599,595 around 16 October 2026https://greeksoup.ai/stocks/us/beam/planned-sales/us:BEAM:planned-sale:2026-10-16:8e49553f67Fri, 16 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: Evans John M. (CEO) sold 25,000 shares (under a trading plan set in advance) at $23.98 on 16 October 2026, $599,595https://greeksoup.ai/stocks/us/beam/insiders/us:BEAM:insider:2026-10-16:3cb660717cFri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: Evans John M. (CEO) sold 25,000 shares (under a trading plan set in advance) at $23.57 on 15 October 2026, $589,150https://greeksoup.ai/stocks/us/beam/insiders/us:BEAM:insider:2026-10-16:fca90a9e44Fri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: Form 144, JOHN M EVANS plans to sell 25,000 shares worth $589,150 around 15 October 2026https://greeksoup.ai/stocks/us/beam/planned-sales/us:BEAM:planned-sale:2026-10-15:75f664d172Thu, 15 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: short interest 26,243,605 shares at the 15 October 2026 settlement, 14.12 days to coverhttps://greeksoup.ai/stocks/us/beam/short-interest/us:BEAM:short-interest:2026-10-15:ab89bf3aa4Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: Cavanagh Bethany J (SVP, Finance and Treasurer) sold 187 shares (under a trading plan set in advance) at $24.41 on 1 October 2026, $4,565https://greeksoup.ai/stocks/us/beam/insiders/us:BEAM:insider:2026-10-02:420ba5e6a9Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: short interest 27,548,815 shares at the 30 September 2026 settlement, 15.30 days to coverhttps://greeksoup.ai/stocks/us/beam/short-interest/us:BEAM:short-interest:2026-09-30:34e7dddc70Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: short interest 25,884,796 shares at the 15 September 2026 settlement, 12.59 days to coverhttps://greeksoup.ai/stocks/us/beam/short-interest/us:BEAM:short-interest:2026-09-15:4199f150bdTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: short interest 25,802,667 shares at the 31 August 2026 settlement, 14.84 days to coverhttps://greeksoup.ai/stocks/us/beam/short-interest/us:BEAM:short-interest:2026-08-31:5cdb3cbd09Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: Schedule 13G/A filed by ARK Investment Management LLC, 9.9% of the classhttps://greeksoup.ai/stocks/us/beam/holders/us:BEAM:schedule-13:2026-08-14:ed785b3ee5Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: short interest 24,374,054 shares at the 14 August 2026 settlement, 16.08 days to coverhttps://greeksoup.ai/stocks/us/beam/short-interest/us:BEAM:short-interest:2026-08-14:8148ad2609Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: Schedule 13G/A filed by Farallon Capital Management, L.L.C., 10.0% of the classhttps://greeksoup.ai/stocks/us/beam/holders/us:BEAM:schedule-13:2026-08-13:73a9d92f0dThu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc. Q2 FY2026 results: revenue $490,000, net income -$123 millionhttps://greeksoup.ai/stocks/us/beam/results/fy2026-q2/us:BEAM:result:2026-08-04:19d0b766c1Tue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/beam/filings/us:BEAM:filing:2026-08-04:c49572cdd9Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/beam/filings/us:BEAM:filing:2026-08-04:112ade7ba8Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Beam Therapeutics Inc.: short interest 23,498,484 shares at the 31 July 2026 settlement, 11.31 days to coverhttps://greeksoup.ai/stocks/us/beam/short-interest/us:BEAM:short-interest:2026-07-31:979a4eb1aaFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>